Acadia Healthcare Company Valuation
Is ACHC * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ACHC * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ACHC * (MX$1084.05) is trading above our estimate of fair value (MX$162.26)
Significantly Below Fair Value: ACHC * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ACHC *?
Key metric: As ACHC * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is ACHC *'s PE Ratio? | |
|---|---|
| PE Ratio | 13x |
| Earnings | US$280.73m |
| Market Cap | US$3.66b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.8x |
| Enterprise Value/EBITDA | 8.3x |
| PEG Ratio | 1.1x |
Price to Earnings Ratio vs Peers
How does ACHC *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24.5x | ||
MEDICA B Médica Sur. de | 8.4x | 11.9% | Mex$3.0b |
4004 Dallah Healthcare | 31.4x | 14.5% | ر.س14.8b |
BURJEEL Burjeel Holdings | 24.7x | 25.4% | د.إ11.6b |
NH Narayana Hrudayalaya | 33.3x | 13.6% | ₹255.7b |
ACHC * Acadia Healthcare Company | 13x | 11.6% | Mex$3.7b |
Price-To-Earnings vs Peers: ACHC * is good value based on its Price-To-Earnings Ratio (13x) compared to the peer average (24.5x).
Price to Earnings Ratio vs Industry
How does ACHC *'s PE Ratio compare vs other companies in the Global Healthcare Industry?
| 13 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 13 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: ACHC * is good value based on its Price-To-Earnings Ratio (13x) compared to the Global Healthcare industry average (20.7x).
Price to Earnings Ratio vs Fair Ratio
What is ACHC *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 13x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ACHC *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Médica Sur. de
Mex$3.0b
Operates as a healthcare hospital in Mexico.
MEDICA B
Mex$29.00
7D
-3.3%
1Y
-30.6%
ZimVie
US$186.2m
Develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
ZIMV *
US$230.00
7D
0%
1Y
n/a
M3
JP¥880.0b
Provides medical-related services primarily to physicians and other healthcare professionals through Internet.
2413 N
JP¥183.50
7D
0%
1Y
n/a